A distribution partnership rarely fails suddenly. It drifts. Case volume plateaus. Communication slows. The energy that marked the launch fades into routine. By the time the numbers make the problem undeniable, months of momentum are already lost. Manufacturers who protect their partnerships watch for early signals and act before the drift sets in.
Reading those signals takes attention to more than the sales figures. Here is what to watch for and how to address it.
Watch for a plateau after early growth
Healthy partnerships show a growth curve in the first year. New surgeons complete first cases. Some schedule second and third cases. Referrals begin to generate introductions. When that curve flattens earlier than expected, something has stalled. It could be the clinical support, the patient selection, or the surgeon experience. The plateau itself is the signal to investigate.
Notice when communication slows
Early in a strong partnership, field feedback flows steadily. The distributor reports surgeon reactions, technique observations, and questions from the OR. When that flow slows, it often means the representatives are less engaged with your product, or that surgeon interest has cooled. Watch for:
- Fewer field observations coming back from the distributor.
- Longer gaps between check-ins.
- Questions that suggest the product has moved down the priority list.
Communication is a leading indicator. It slows before the numbers do.
Track first-case-to-second-case conversion
The single most useful early metric is not total case volume. It is how many surgeons who complete a first case go on to a second. A partnership where first cases happen but second cases do not is telling you something specific. The surgeon experience is not strong enough to drive adoption. That signal appears well before total volume reflects the problem.
Act on the signals early
When you see these signals, address them directly. Talk with your distributor about what the field feedback shows. Ask what support the representatives need. Review whether your clinical materials and training gave them enough to succeed. Often the fix is a stronger support investment, not a new distributor.
Synchrocare's medical sales consultants are trained to represent every product in the portfolio at a clinical standard that earns OR standing. When a manufacturer partner invests in field support and responds quickly to feedback, the partnership has what it needs to recover momentum. The signals are only useful if you act on them while there is still momentum to protect.
To learn more about partnering with Synchrocare as your specialty distribution partner, visit www.synchrocare.com.

